Cargando…

A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis

PURPOSE: We explored the mechanism of Shugan Jianpi Formula (SGJPF) and its effective components for the treatment of liver fibrosis (LF). MATERIALS AND METHODS: We collected the active ingredients in SGJPF through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Chang, Wu, Fu Rong, Zhang, Jia Fu, Jiang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306883/
https://www.ncbi.nlm.nih.gov/pubmed/32617108
http://dx.doi.org/10.1155/2020/4780383
_version_ 1783548736761233408
author Fan, Chang
Wu, Fu Rong
Zhang, Jia Fu
Jiang, Hui
author_facet Fan, Chang
Wu, Fu Rong
Zhang, Jia Fu
Jiang, Hui
author_sort Fan, Chang
collection PubMed
description PURPOSE: We explored the mechanism of Shugan Jianpi Formula (SGJPF) and its effective components for the treatment of liver fibrosis (LF). MATERIALS AND METHODS: We collected the active ingredients in SGJPF through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and screened the effective components by absorption, distribution, metabolism, and excretion. Herb-associated target proteins were predicted and screened based on the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine and Search Tool for Interactions of Chemicals databases. LF-associated target proteins were predicted and screened based on the Online Mendelian Inheritance in Man® Database and Comparative Toxicogenomics Database. Common genes with LF and herbs were selected, and Cytoscape 3.5.1 software was used to construct an herb pathway and component-LF common target network. The Search Tool for the Retrieval of Interacting Genes/Proteins was used to build a protein-protein interaction, and quantitative PCR was used to verify the related target genes. Finally, clusterProfiler was applied for the analysis of Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways. RESULTS: The pharmacological network contained 252 active compounds (e.g., Astragaloside A, saikosaponin, linoleic acid, and Poria acid A), 84 common target genes, and 94 significant signaling pathways. Among them, interleukin 6 (IL-6), tumor protein 53 p53 (TP53), prostaglandin-endoperoxide synthase 2 (PTGS2), AKT1, IL-1β, and the nucleotide-binding and oligomerization domain-like receptor and Janus kinase-signal transducer and activator of transcription signaling pathways were selected as the critical target gene and critical signal pathway, respectively. CONCLUSION: The mechanisms of SGJPF in protecting against LF include the regulation of multiple targets such as IL-6, TP53, PTGS2, and AKT1. These target proteins affect LF through various signal transduction pathways.
format Online
Article
Text
id pubmed-7306883
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73068832020-07-01 A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis Fan, Chang Wu, Fu Rong Zhang, Jia Fu Jiang, Hui Evid Based Complement Alternat Med Research Article PURPOSE: We explored the mechanism of Shugan Jianpi Formula (SGJPF) and its effective components for the treatment of liver fibrosis (LF). MATERIALS AND METHODS: We collected the active ingredients in SGJPF through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and screened the effective components by absorption, distribution, metabolism, and excretion. Herb-associated target proteins were predicted and screened based on the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine and Search Tool for Interactions of Chemicals databases. LF-associated target proteins were predicted and screened based on the Online Mendelian Inheritance in Man® Database and Comparative Toxicogenomics Database. Common genes with LF and herbs were selected, and Cytoscape 3.5.1 software was used to construct an herb pathway and component-LF common target network. The Search Tool for the Retrieval of Interacting Genes/Proteins was used to build a protein-protein interaction, and quantitative PCR was used to verify the related target genes. Finally, clusterProfiler was applied for the analysis of Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways. RESULTS: The pharmacological network contained 252 active compounds (e.g., Astragaloside A, saikosaponin, linoleic acid, and Poria acid A), 84 common target genes, and 94 significant signaling pathways. Among them, interleukin 6 (IL-6), tumor protein 53 p53 (TP53), prostaglandin-endoperoxide synthase 2 (PTGS2), AKT1, IL-1β, and the nucleotide-binding and oligomerization domain-like receptor and Janus kinase-signal transducer and activator of transcription signaling pathways were selected as the critical target gene and critical signal pathway, respectively. CONCLUSION: The mechanisms of SGJPF in protecting against LF include the regulation of multiple targets such as IL-6, TP53, PTGS2, and AKT1. These target proteins affect LF through various signal transduction pathways. Hindawi 2020-06-12 /pmc/articles/PMC7306883/ /pubmed/32617108 http://dx.doi.org/10.1155/2020/4780383 Text en Copyright © 2020 Chang Fan et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fan, Chang
Wu, Fu Rong
Zhang, Jia Fu
Jiang, Hui
A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
title A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
title_full A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
title_fullStr A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
title_full_unstemmed A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
title_short A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis
title_sort network pharmacology approach to explore the mechanisms of shugan jianpi formula in liver fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306883/
https://www.ncbi.nlm.nih.gov/pubmed/32617108
http://dx.doi.org/10.1155/2020/4780383
work_keys_str_mv AT fanchang anetworkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT wufurong anetworkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT zhangjiafu anetworkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT jianghui anetworkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT fanchang networkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT wufurong networkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT zhangjiafu networkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis
AT jianghui networkpharmacologyapproachtoexplorethemechanismsofshuganjianpiformulainliverfibrosis